SlideShare a Scribd company logo
This PowerPoint Presentation done by dr.Osama Khalil
Obstetrics and Gynecology Department
Ain Shams University
Heart disease in pregnancy is very rare but potentially serious and complicates
approximately 1% of all pregnancies. This Prevalence varies from one
community to another principally because the incidence of rheumatic heart
disease and undiagnosed or uncorrected congenital heart disease is higher in
developing countries.
Etiology
• Rheumatic valve “commonest in Egypt and developing countries”
• Congenital Heart diseases “commonest in developed countries”
• Others: e.g. Arrhythmia and ischemic heart diseases “rare”
A. Text
here
C. Text here
physiological changes in CVS during pregnancy
Irrespective of the underlying condition;
pregnancy imposes a significant burden
on the heart due to normal physiological
changes occur; both blood volume and
cardiac output are changed. The changes
are classified in: Vascular resistance
and blood pressure
The Heart
a. Lateral displacement of the Apex:
in late pregnancy (to the 4th intercostal space)
occur due to elevation of the diaphragm and the
heart by the fundus of growing uterus.
b. Functional systolic murmurs:
due to hyper dynamic circulation of the
dilutional anemia.
Cardiac Output
a. Preload: is increased due to associated
Rise in the blood volume " main cause".
b. Afterload: is reduced due to the
decline in systemic vascular resistance.
c. Maternal heart rate:
rises by 15-20 beats/min
rises to a peak at 28 to 34 weeks which is 30-50% above baseline because:
Vascular resistance and Blood pressure
BP typically fall early in gestation to about 5-10 mmHg below the baseline
in
the 2nd trimester "mean of about 105/60 mmHg". In 3rd trimester BP
gradually increases and may normalize to non-pregnant values by term.
The
fall in BP is reduced by a reduction in systemic vascular resistance due to:
a. Uteroplacental circulation. b. Systemic Vasodilatation
Supine Hypotension $
In the 2nd half of pregnancy; maternal hypotension
occurs in supine position due to pressure of pregnant
uterus on the IVC this leads to Decrease venous return
and cardiac output.
The Veins
Varicose veins, ankle edema and piles due to pressure by uterus on
pelvic veins, progesterone effect and increased blood volume.
NYHA (New York Heart Association) Functional grading of heart disease
Grade Symptoms Degree of compromise
I No limitation of physical activity- asymptomatic with
normal activity
Uncompromised
II : Mild limitation of physical activity -Symptoms with
normal physical activity
Slightly compromised
III : Marked limitation of physical activity -Symptoms
with less than normal activity, comfortable at rest
Markedly compromised
IV Severe limitation of physical activity- symptoms at
rest
Severely compromised
Grade I and II = 80% of the patientscompensated
heart
Grade III and IV 20% of the patients
decompensated heart
Diagnosis of Cardiac diseases during pregnancy including:
History Taking
Examinations
Investigations
History Taking
Clinical Features of Normal
pregnancy Mimic Heart Disease
SYMPTOMS :
1- Dyspnea.
2- Orthopnoea.
3- Paroxysmal Nocturnal Dyspnea.
4- Easy fatigue.
5- Dizziness.
Clinical indications of the Heart
Disease during pregnancy
SYMPTOMS :
1- Progressive Dyspnea or Orthopnoea.
2- Chest pain.
3- Nocturnal Cough.
4- Hemoptysis.
5- Syncope.
Examinations
Clinical Features of Normal
pregnancy Mimic Heart Disease
SIGNS :
1- Increased Pulse Rate.
2- Water Hummer Pulse.
3- Systolic Murmur.
4- Left Axis Deviation.
5- Edema.
6- congested Neck veins.
Clinical indications of the Heart
Disease
during pregnancy
SIGNS :
1- Cyanosis.
2- Clubbing Of fingers.
3- Persistent Arrhythmia.
4- Persistent Neck Veins.
5- criteria or Pulmonary HTN.
6- Cardiomegaly .
7- Diastolic Murmur.
8- Systolic Murmur more than or Equal grade 3/6.
9- Persistent split 2nd sound.
Investigations
1- Echocardiogram. cardiac status and structural anomalies
2- ECG.
3- Catheterization rarely done, if done guided by
transesophageal U/S.
Next
Effect of pregnancy on heart disease
(medical complications)
Effect of heart disease on pregnancy
(Obstetric complications)
• Worsening of cardiac status:
Decomposition ( heart failure):
a) During pregnancy: Increase COP
at 28 -32 WKS.
b) During labor: due to stress of
labor .
c) After delivery: the most
dangerous period due to
sudden return the blood to
general circulation.
• Bacterial endocarditis,
pulmonary edema, pulmonary
embolism, rupture of aneurism
specially during labor.
•Polyhydromaninos as a part of systemic
venous congestion.
•PPH: atonic due to uterine ischemia.
•Puerperal sepsis and secondary
postpartum hemorrhage.
•Defective lactation.
The Fetus is at increased risk of growth restriction and preterm delivery in pregnancies
complicated by cyanotic congenital heart disease. When
total fetal lose rate may be as higher as 40%. Uncorrected coarctation of aorta is
associated with fetal growth restriction in more than 10% of cases due to reduced
placental perfusion. The incidence of congenital Heart disease in general population is8
per 1000 live born babies if a parent is affected the risk is increase to 5%.
Therefore all pregnant women with congenital heart disease should be Referred for
export fetal cardiology scanning
•Abortion especially with cyanotic heart disease or due to teratogenic drugs
•Congenital fetal malformation due to chronic hypoxia or teratogenic drugs
•IUGR.
•Congenital heart disease in baby 5%.
•Neonate anemia and hypoxia.
The three categories are lesions that produce
volume overload, lesions that produce pressure
overload, and lesions that produce cyanosis.
Other cardiac conditions which have their own
unique issues are Cardiomyopathy, coronary
artery disease and Marfans syndrome.
1-Volume overload lesions
•Atrial septal defects
•Ventricular septal defects
•Patent ductus arteriosus
•Mitral and aortic regurgitation (insufficiency
2-Pressure overload lesions
•Congenital aortic stenosis
•Coarctation of the aorta
•Pulmonary valve stenosis
•Rheumatic mitral stenosis
3-Cyanotic congenital disease heart
•Ebstein’s anomaly
•Tetralogy of Fallot
Atrial septal defects
The most common congenital lesions in adults are atrial
septal defects and they may be first diagnosed during
pregnancy The expected 50% increase in blood volume
during pregnancy causes further volume loading, although
usually without a concomitant increase in pulmonary
artery pressures. Most patients with an isolated ASD
tolerate pregnancy well; good left ventricular ejection
fraction and NYHA functional status are predictive of
uncomplicated and successful outcomes With larger defects
and shunts, there is risk for congestive heart failure,
atrial arrhythmias, peripheral venous thrombosis or
embolism, cerebral vascular accidents, and shunt reversal
with cyanosis from sudden systemic hypotension.
1-Volume overload lesions
1-Volume overload lesions
Ventricular septal defects
Clinical sequelae and symptoms manifest as exercise
intolerance, dyspnea or congestive heart failure are most likely
to happen if the VSD is large in size and therefore exerts a
hemodynamic effect. Infective endocarditis, however, can occur
with any size of VSD. Similarly to ASD, VSD should be repaired if
symptomatic, large (a Qp:QS ratio of >1.5:1) or associated with
an elevation in pulmonary artery pressure. Isolated VSD are
usually well tolerated in pregnancy unless the size is large and
degree of shunting places a large volume burden on the system;
peripartum risks are determined by parameters which reflect
the degree of shunting: left ventricular size and function,
pulmonary artery pressures, and the patient’s functional class.
In hemodynamically significant shunts, complications include
congestive heart failure, atrial arrhythmias, worsening
pulmonary artery hypertension, and shunt reversal with
cyanosis due to systemic hypotension. In a study from
Connecticut, USA, in the 1970s, there were no maternal deaths
reported in 98 pregnancies resulting in 78 liveborn infants in 50
women with VSD ,In women with corrected lesions, no
increased risks are associated with gestation.
Patent ductus arteriosus
the risks of pregnancy are related to shunt size and
degree of pulmonary hypertension. Clinical symptoms and
complications are also similar to those associated with
VSD. In corrected or uncorrected patent ductus arteriosus,
pulmonary hypertension significantly increases maternal
and fetal morbidity and mortality rates
1-Volume overload lesions
1-Volume overload lesions
Mitral and aortic regurgitation (insufficiency)
Valvular regurgitation may be due to rheumatic disease, prolapse or endocarditis. It can
also occur in relation to ischemic heart disease and dilated cardiomyopathies. Trivial or
physiologic regurgitation of the mitral valve is present in up to 70% of normal patients on
echocardiography; it is not audible and is of no clinical significance. Complications occur
from valvular regurgitation as a result of chronic volume overload and related atrial or
ventricular strain and can include arrhythmias (especially atrial fibrillation in the setting of
mitral regurgitation), pulmonary hypertension (particularly from chronic severe mitral
insufficiency or congestive heart failure. If found in isolation, these lesions are usually well
tolerated in pregnancy. Due to the favorable effects of decreased systemic vascular
resistance and consequent afterload reduction in pregnancy, even severe regurgitation does
not exhaust the cardiac reserve. On the other hand, those patients with chamber
enlargement or ventricular dysfunction have higher rates of peripartum heart failure and
this should be anticipated
Rheumatic mitral stenosis
Patients with mild stenosis are asymptomatic. Those
with moderate stenosis are asymptomatic at rest.
Symptoms can include limited exercise tolerance,
dyspnea on exertion or, when supine, hemoptysis,
and pedal edema. Unless the mitral stenosis is
severe, most patients are asymptomatic.
2-Pressure overload lesions
Coarctation of aorta Risk of
rupture in late pregnancy or
labor
Coarctation of the aorta
The risks of pregnancy in women with aortic coarctation include
worsening hypertension, new-onset heart failure and, rarely but
ominously, aortic dissection and rupture .Ideally, moderate-to-
severe aortic coarctation should be repaired, with balloon
angioplasty or stenting, or replacement prior to pregnancy
2-Pressure overload lesions
aortic stenosis
Left-sided congestive failure
Congenital aortic stenosis
Isolated mild-to-moderate valvular aortic stenosis is well tolerated in
pregnancy, but severe aortic stenosis (aortic valve area (AVA)
<1.0 cm2 – the normal aortic valve area is 3–4 cm2) is associated with
increased maternal and fetal morbidity and mortality rates.
2-Pressure overload lesions
Pulmonary valve stenosis
Patients with unrepaired mild-to-moderate pulmonary stenosis (gradients
less than 40 mmHg; normally there should be no gradient across any valve)
are usually asymptomatic and tolerate the hemodynamic burden of
pregnancy with a low incidence of complications In patients with more
severe obstruction and worsening clinical function, Percutaneous balloon
valvuloplasty can be done during pregnancy.
2-Pressure overload lesions
Ebstein’s anomaly
In this uncommon congenital heart lesion, a malformed tricuspid valve
is apically displaced to a variable extent with resultant tricuspid
regurgitation, atrial dilation, and limited right ventricular function.
Severe cases present in infancy, but many cases will first present in
teenagers or adults. Complications include CHF, arrhythmias, and
paradoxical embolism. Associated abnormalities are frequent and
include ASD (50%) and the Wolff–Parkinson–White (WPW) syndrome
(30%) . Most patients can be treated medically but more severe forms
may develop right heart failure and require surgical correction.
Preconception repair is preferred to reduce morbidity and mortality
Approximately 70% of women with Ebstein’s anomaly have an
interatrial shunt, and therefore these women are also at risk for
paradoxic emboli (venous thromboembolism that passes through an
ASD into the left atrium and thereby the systemic-arterial
circulation to cause stroke or peripheral embolism).
3-Cyanotic congenital disease heart
3-Cyanotic congenital disease heart
Tetralogy of Fallot
The most common cyanotic congenital heart defect found in children, adults,
and pregnant women In a recent retrospective study of 50 pregnancies that did
not end in abortions in 26 women, the maternal complication rate was 12% (of
pregnancies) and 19% (of patients) cardiac complications included symptomatic
right-sided heart failure in two cases and arrhythmias (three ventricular and
three supraventricular) All patients were NYHA class I prior to pregnancy. The
two patients with heart failure were noted to have severe pulmonary
insufficiency which would further increase the volume load on the right
ventricle . On the other hand, uncorrected or palliated lesions can be expected
to have clinical deterioration during pregnancy, resulting in increased maternal
and fetal complications In these patients, maternal risks include increased right-
to-left shunting via a residual VSD due to the normal fall in systemic vascular
resistance and, thus, worsening cyanosis during gestation and delivery;
biventricular heart failure; arrhythmias; and cerebral vascular accidents from
paradoxic emboli. Fetal risk is correlated with maternal hypoxia and includes a
very high rate of prematurity, low birthweight, and spontaneous abortion .
Maternal cardiac arrhythmias
Maternal cardiac arrhythmias are occasionally
encountered during pregnancy. Paroxysmal atrial
tachycardia is the most commonly encountered
maternal arrhythmia and is usually associated
with overly strenuous exercise. Underlying cardiac
disease such as mitral stenosis should be
suspected when atrial fibrillation and flutter are
encountered
Other cardiac disease
Peripartum Cardiomyopathy:
Peripartum Cardiomyopathy is an unusual but
especially severe cardiac condition identified in
the last month of pregnancy or the first 6
months following delivery. It is difficult to
distinguish from other cardiomyopathies (e.g.,
myocarditis) except for its association with
pregnancy. In many cases, no apparent cause can
be determined.
Other cardiac disease
Eisenmenger’s syndrome.
if right-to-left shunt—pulmonary
hypertension.
Other cardiac disease
•Artificial valves—thrombosis
Coronary artery disease
Atherosclerotic coronary artery disease is rare in premenopausal
women, but with increases in smoking, obesity, diabetes and delayed
childbearing, ischemic heart disease is now being seen in pregnancy
more frequently. Pregnancy increases the risk of myocardial infarction
3–4-fold. Acute myocardial infarction was reported to occur with a
frequency of 10/100,000 deliveries and a Medline search of case
reports suggests a very high maternal mortality rate (19–35%)
Other cardiac disease
Cardiac transplantation
The number of women deciding to become pregnant after cardiac transplantation has increased as more recipients are surviving longer and with an
improved quality of life. Pregnancy does not appear to have an adverse effect with respect to cardiac function or episodes of rejection
Other cardiac disease
Marfan’s syndrome
Pregnancy in women with the Marfan syndrome carries risk for worsening aortic dilation,
aortic valve regurgitation, congestive heart failure, and, more ominously, acute aortic
dissection and death Preconception aortic replacement or pregnancy termination should be
strongly considered for patients with ascending aortic diameters greater than or equal to
4.5 cm On the other hand, women without aortic dilation or cardiovascular complications
appear to tolerate pregnancy well
Other cardiac disease
Ehlers–Danlos type IV
Type IV or vascular EDS is the most dangerous type of EDS and may result in death related
to arterial, intestinal and uterine fragility or rupture. The heredity pattern is autosomal
dominant. Overall life expectancy is estimated to be 40–50 years, and most deaths are
secondary to arterial rupture. Maternal mortality rate is approximately 12%, with the
greatest risk of complications occurring during labor, delivery and early postpartum periods.
Although uterine rupture has been cited as the most common cause of maternal mortality
related to EDS type IV.
Other cardiac disease
For all women with CHD, counseling about future pregnancies and contraception should
begin in adolescence to prevent accidental and potentially dangerous pregnancies. To
obtain correct and complete information for risk stratification, a thorough evaluation should be
performed including
• Review of past medical records,
• Assessment of current functional status,
• Physical examinations,
• Pulse oximetry,
• Electrocardiogram,
• Imaging studies,
• Cardiopulmonary
• Exercise test and the use of Halter monitors.
Risk stratifications of preconception management
Risk assessment, by modified World Health Organization (WHO) risk classification, was
recommended by the European Society of Cardiology (ESC) to estimate the risk of pregnancy in
women with heart disease Four risk classes (WHO I, II, III and IV) were defined according to both
specific heart lesions and the clinical cardiac status The categories ranged from the very low risk of
WHO class I to the highest risk of WHO class IV, which was considered the contraindication for
pregnancy.
The table in the Next slide
WHO I
No significant risk elevation
WHO II
depending on individual
Mildly to moderately
elevated risk
WHO III
Significantly elevated risk
WHO IV
High risk
(pregnancy contraindicated)
•Uncomplicated, small or mild
-pulmonary stenosis
-patent ductus arteriosus
-Mitral valve prolapse
• Successfully repaired simple
lesions
-atrial or ventricular
septal defect,
-patent ductus arteriosus-anomalous p
ulmonary
venous drainage.
•Atrial or ventricular ectopic beats,
isolated WHO II Mildly elevated
Risk.
•Unoperated atrial or
ventricular septal defect (no
elevated pulmonary artery
pressure)
• Repaired tetralogy of Fallot
(without relevant residua
or sequelae)
• Most arrhythmias
• Mild left ventricular
Impairment.
•Hypertrophic
Cardiomyopathy.
•Native or tissue valvular
heart disease not
Considered WHOI or IV
•Marfan syndrome
without aortic dilatation.
•Aorta < 45 mm in aortic
disease associated with
bicuspid aortic valve.
•Repaired coarctation
•Non-severe systemic ventricular
dysfunction.
•Mechanical valve.
•Systemic right ventricle.
•Cyanotic heart disease
(unrepaired without pulmonary
hypertension).
•Other complex congenital heart
Disease.
•Aortic dilatation 40-45 mm in
Marfan syndrome.
• Aortic dilatation 45-50 mm in
aortic disease associated with
bicuspid aortic valve.
•Pulmonary arterial
hypertension of any cause
• Severe systemic ventricular
dysfunction (LVEF < 30%,
NYHA III-IV).
• Previous peripartum
Cardiomyopathy with any
residual impairment of left
ventricular function.
•Severe mitral stenosis, severe
symptomatic aortic stenosis,
severe coarctation.
•Marfan syndrome with aorta
dilated > 45 mm.
• Aortic dilatation > 50 mm in
aortic disease associated with
bicuspid aortic valve
• Native severe coarctation
The flowchart for preconception assessment and counseling for women with congenital heart
disease. CPX, cardiopulmonary exercise test; PE and WHO
Antenatal Management
•Place
In most of cases, patients are followed up in special cardiac out patient clinic under
Under supervision of both obstetricians, cardiologists and anesthesiologist .
Antenatal care visits more frequent for adequate follow up of maternal cardiac state
And fetal well-being.
Indication of hospitalization includes:
1) Cases of class II at 24-32 weeks of pregnancy.
2) Cases of class III and IV are admitted earlier and for longer periods.
3) Near term to plan for delivery.
Antenatal Management
•Drug therapy
a) Prophylaxis against rheumatic activity  antibiotics
Indication: patients with rheumatic heart lesion
Drug used:
1) Long acting penicillin or daily penicillin
2) Erythromycin (if sensitive to penicillin)
b) Prophylaxis against of infective endocarditis  antibiotics
Indications:
- Patients need prophylaxis : patient with problems affecting the structure of the
Heart (e.g. replacement heart valve congenital heart disease hypertrophic Cardiomyopathy.
patient with pervious history of Invective Endocarditis.
- Conditions need prophylaxis: Before any minor surgery (e.g. tooth extraction) and labor or CS
Drug used:
a) At onset of labor or ROM to prior to CS or minor surgery by ½ hour.
 Amoxicillin 1or 2 gm IV plus
b) Then: amoxicillin 500 mg oral after 6 hours
c) For women who are allergic to penicillin: vancomycin 1 gm IV.
Next
Antenatal Management
•Drug therapy
c) Prophylaxis against thrombosis antithrombotic drugs
Indication: for patients with metallic valves.
Drug used: choice of 3 regimens:
1) LMWH through out pregnancy, weight-adjusted dose with anti-Xa level monitoring
2) Warfarin through out pregnancy, if can keep warfarin less than or equal 5 mg e.g. INR 2-3 in
aortic prosthesis, sinus rhythm, change to LMWH or UFH at 36 weeks.
3) LMWH until 13 weeks, and then warfarin and aspirin until 36 weeks; change to LMWH or UFH
until labor. Monitoring anti-Xa level with LMWH.
d) Treatment of heart failure and Acute pulmonary edema:
 Fowler position
 Opioid (morphine)
 Oxygen
 Drugs: Digitalis Diuretics  Frusemide 20-25 mg. Dilators  Hydralazine in hypertension
Antenatal Management
•Surgery in Pregnancy
A) Balloon catheterization or even closed heart operation: could be done in 2nd trimester
in case of severe mitral stenosis.
B) Valve Replacement: indicated only in life threaten cases during pregnancy; as it need open
heart surgery with heart-lung machine
Antenatal Management
•Follow Up
a) Maternal condition:
 Routine antenatal tests.
 Cardiac assessment and early detection of heart failure
 Recognition of risk factors “anemia, infection Or hypertension”.
 Investigations “Echocardiogram, ECG, CBC and sputum culture for chest infection
b) Fetal condition:
Follow up of fetal kicks with regular tests of fetal wellbeing.
•Other instructions and interventions
 No heavy work and bed rest; 9 hours by night, 2 hours by day.
 Guard against excessive weight gain.
 Salt restrictions.
 Correction of anemia.
 Dental care and use of an umbrella of antibiotics when there is tooth extraction
 Control of any Risk Factors eg. Anemia, infection Or hypertension.
 Antenatal corticosteroids if preterm labor occurs or is indicated.
Termination of pregnancy
•Indications:
a) Gestational age:
 Pregnant women with cardiac disease who are considered functionally normal be allowed to go in to labor
spontaneously
 If there are any concerns about the functional adequacy of the heart and circulation, labor should be induced under
controlled conditions the timing of induction is individualized taking into account the patient cardiac status inducibility
of the cervix fetal lung maturity.
b) Maternal condition:
development of obstetric or medical complication inducing delivery.
c) Fetal condition:
Non-reassuring fetal rate evaluation, non-reassuring biophysical scores, IUFD or malformation
Incompatible with life
d) Other indication for termination: e.g the patient is in labor
Termination of pregnancy
•Mode of termination:
a) Vaginal delivery:
 Virtually all women with cardiac disease can expect to attempt vaginal delivery because it poses less cardiac risk than cesarean delivery.
A long induction in a woman with an unfavorable cervix should be avoided
b) Cesarean delivery:
 Should be reserved for obstetric indications such as :
- Fetal heart tracing is non-reassuring and vaginal delivery is not imminent.
- Vaginal delivery is contraindicated eg. Placenta previa, prior classical cesarean delivery
- Vaginal delivery is unsuccessful “ Failure to progress”
 Cesarean delivery in cardiac diseased women is indicated in
- Pre-term labor in patient on oral anti-coagulants.
- Marfan and other ascending aortic aneurysms.
- Aortic dissection.
- Severe Aortic stenosis.
- Eisenmenger’s syndrome.
The concerns about cesarean delivery
- General anesthesia, if required, incurs the risk of hemodynamic
instability.
-CS is accompanied by blood loss that is about twice as great as with
vaginal delivery.
-There are increased risks of wound and uterine infection.
-Postoperative thrombophlebitis is more common after CS.
-The risk of postoperative incisional bleeding is high in patients requiring
anticoagulants.
Termination of pregnancy
•Intra-partum Management :
 Delivery in semi-sitting (Fowler) position with adequate oxygenation.
 Staining is prohibited, to minimize venous return and decrease heart rate.
 Proper pain relief to minimize anxiety and tachycardia.
 Close observation to avoid PPH.
 Avoid early ROM and Excessive PV to avoid infection.
 Fluid restriction and anti-failure measures in cases at high risk for heart failure.
 Antibiotic prophylaxis against Infective Endocarditis.
 Shorten the second stage by low-forceps when necessary.
Epidural anesthesia may sometimes cause systemic hypotension, so it
contraindicated in cases with right-left shunt. Also it is not suitable for patients on
anticoagulants
Termination of pregnancy
•Post-Partum Management :
 Measures to avoid PPH:
- Oxytocin should be infused slowly (less than 2 units/min) to avoid hypertensive effect.
- Ergometrin should be avoided in most patients (high rate of vasoconstriction and elevation of blood pressure
 Hemodynamic monitoring of the mother is warranted for 12-24 hours after delivery.
 In patients requiring prolonged bed rest:
- Meticulous leg care.
- Elastic support stockings.
- Early ambulation are important preventive measures that reduce the risk of VTE.
 Warfarin is started 2-3 days post-partum if patient is on anticoagulant therapy.
 Prophylaxis and treatment of expected anemia.
 Prophylactic antibiotics against sepsis.
 Anti-D Ig should be given to all non-sensitized RhD-negative women.
 Care of the neonate.
 Breast-feeding is contraindicated only if there is heart failure.
 Proper selection of a method of contraception, for adequate pregnancy spacing.
In pregnant women with cardiac disease
Which cardiac patients should be referred to hospital for an abortion?
• Congenital – Cyanotic disease, right/left ventricular dilatation, uncontrolled
tachyarrhythmia
• Coronary disease  History of AMI, treatment angina.
• Cardiomyopathy Dilated, hypertrophic, history of peripartum CMP.
• Valvular disease  Significant aortic/mitral stenosis
 Aortic/mitral regurgitation with LV dilatation.
Abortion in women with significant cardiac disease
• Identify the women with cardiovascular disease by -European Society of Cardiology
guidelines or WHO Classifications
• Consult a cardiologist – Not all cardiac diseases are alike
• Consult an anesthesiologist experienced in cardiac anesthesia
– Follow selected patients (pulmonary hypertension!) long enough(at least overnight)
Medical vs. surgical abortion in women with significant cardiac disease
The medical abortion method is also referred to as the “abortion pill” method. Medical abortion is an
abortion caused by medicine rather than surgery. Two medications are used in medical abortions:
Mifepristone and misoprostol. It is only available in women who are less than 7 weeks pregnant
Cervical
Ripening
MIFEPRISTONE
Causes progesterone blockade
Decidual
Necrosis
Detachment
MISOPROSTOL
Causes uterine cramping & expulsion
A surgical abortion also known as aspiration abortion, empties the contents of your uterus and
is usually performed within 12-14 weeks from your last normal menstrual period.
Two types of surgical abortion:
Vacuum Aspiration
Manual Vacuum Aspiration (MVA) removes the fetus/embryo by suction using a manual syringe.
Electric Vacuum Aspiration (EVA) which uses an electric pump to remove the fetus/embryo.
Dilation and Evacuation is done in the second 12 weeks (2nd trimester) of pregnancy. It
usually includes a combination of vacuum aspiration, dilation and curettage (D&C), and the use
of surgical instruments (such as forceps).
Medical vs. surgical abortion in women with significant cardiac disease
• Obstetrics book volume I of obstetrics and Gynecology department of faculty of medicine of Ain Shams university
• Obstetric_by_10_Teachers_18th_Edition /Campball lees
• Of obstetrics and Gynecology book sixth edition by Charles R.B. Beckmann, Frank W.Ling, Barbara M. Barzansky, ….etc.
• Lecture Note Obstetrics and Gynecology by Diana Hamilton-Fairley MD, FRCOG Consultant Obstetrician and Gynecologist
Guy’s and St Thomas’s Hospital NHS Trust, London Second Edition
• de Swiet's Medical Disorders in Obstetric Practice Edited by Raymond O. Powrie, MD Michael F. Greene, MDWilliam
Camann, MD WILEY-BLACKWELL
• Nelson-Piercy C. Heart disease. In: Handbook of Obstetric Medicine -- Nelson-Piercy C, ed. (2002) 2nd Edn. Martin Dunitz:
Taylor & Francis Group.
•Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur
Heart J. 2010;31:2124–2132. [PubMed]
• Kaleschke G, Baumgartner H. Pregnancy in congenital and valvular heart disease. Heart. 2011;97:1803–1809. [PubMed]
• European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society forGender
Medicine (DGesGM) Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Committee for Practice Guidelines. ESC
Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on theManagement of
Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) Eur Heart J. 2011;32:3147–
3197. [PubMed]
• Abortion in women with cardiac disease/ Oskari Heikinheimo Dept Ob&Gyn University of Helsinki Soc Fam Plan,
Contraception 2012

More Related Content

What's hot

Heart disease in pregnancy
Heart disease in pregnancy Heart disease in pregnancy
Heart disease in pregnancy
Dato' Dr.Aruku Naidu O&G
 
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
Nishant Thakur
 
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
Muntadhar Haider
 
Heart disease pregnancy new dr rabi
Heart disease pregnancy new dr rabiHeart disease pregnancy new dr rabi
Heart disease pregnancy new dr rabi
Rabi Satpathy
 
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancyraj kumar
 
Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020
mahmoodayub2
 
Heart diseases during pregnancy
Heart diseases during pregnancyHeart diseases during pregnancy
Heart diseases during pregnancy
Ramachandra Barik
 
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
SanaJaved51
 
Heart diseases with preg
Heart diseases with pregHeart diseases with preg
Heart diseases with preg
falling
 
Cardiomyopathy in pregnancy
Cardiomyopathy in pregnancyCardiomyopathy in pregnancy
Cardiomyopathy in pregnancyFahad Zakwan
 
Cardiovascular Diseases on Pregnancy
Cardiovascular Diseases on PregnancyCardiovascular Diseases on Pregnancy
Cardiovascular Diseases on Pregnancy
pogisurabaya
 
Cardiac diseases in pregnancy 30.7.2013
Cardiac diseases in pregnancy 30.7.2013Cardiac diseases in pregnancy 30.7.2013
Cardiac diseases in pregnancy 30.7.2013limgengyan
 
Rupture uterus
Rupture uterusRupture uterus
Rupture uterus
muhammad al hennawy
 
Venous thromboembolism of pregnancy
Venous thromboembolism of pregnancyVenous thromboembolism of pregnancy
Venous thromboembolism of pregnancy
Siti Nurul Afiqah Johari
 
Cardiac Diseases in Pregnancy
Cardiac Diseases in PregnancyCardiac Diseases in Pregnancy
Cardiac Diseases in Pregnancy
Hasan Arafat
 
Obesity in pregnancy
Obesity in pregnancyObesity in pregnancy
Obesity in pregnancy
Hashem Yaseen
 
Abruptio placenta
Abruptio placentaAbruptio placenta
Abruptio placenta
Nirsuba Gurung
 
Peripartum cardiomyopathy
Peripartum cardiomyopathyPeripartum cardiomyopathy
Peripartum cardiomyopathy
Nizam Uddin
 
Intrauterine death
Intrauterine deathIntrauterine death
Intrauterine death
dr.hafsa asim
 
Seminar heart diseases in preg
Seminar heart diseases in pregSeminar heart diseases in preg
Seminar heart diseases in preg
sunanda nimmalapudi
 

What's hot (20)

Heart disease in pregnancy
Heart disease in pregnancy Heart disease in pregnancy
Heart disease in pregnancy
 
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
 
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
 
Heart disease pregnancy new dr rabi
Heart disease pregnancy new dr rabiHeart disease pregnancy new dr rabi
Heart disease pregnancy new dr rabi
 
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
 
Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020
 
Heart diseases during pregnancy
Heart diseases during pregnancyHeart diseases during pregnancy
Heart diseases during pregnancy
 
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
 
Heart diseases with preg
Heart diseases with pregHeart diseases with preg
Heart diseases with preg
 
Cardiomyopathy in pregnancy
Cardiomyopathy in pregnancyCardiomyopathy in pregnancy
Cardiomyopathy in pregnancy
 
Cardiovascular Diseases on Pregnancy
Cardiovascular Diseases on PregnancyCardiovascular Diseases on Pregnancy
Cardiovascular Diseases on Pregnancy
 
Cardiac diseases in pregnancy 30.7.2013
Cardiac diseases in pregnancy 30.7.2013Cardiac diseases in pregnancy 30.7.2013
Cardiac diseases in pregnancy 30.7.2013
 
Rupture uterus
Rupture uterusRupture uterus
Rupture uterus
 
Venous thromboembolism of pregnancy
Venous thromboembolism of pregnancyVenous thromboembolism of pregnancy
Venous thromboembolism of pregnancy
 
Cardiac Diseases in Pregnancy
Cardiac Diseases in PregnancyCardiac Diseases in Pregnancy
Cardiac Diseases in Pregnancy
 
Obesity in pregnancy
Obesity in pregnancyObesity in pregnancy
Obesity in pregnancy
 
Abruptio placenta
Abruptio placentaAbruptio placenta
Abruptio placenta
 
Peripartum cardiomyopathy
Peripartum cardiomyopathyPeripartum cardiomyopathy
Peripartum cardiomyopathy
 
Intrauterine death
Intrauterine deathIntrauterine death
Intrauterine death
 
Seminar heart diseases in preg
Seminar heart diseases in pregSeminar heart diseases in preg
Seminar heart diseases in preg
 

Viewers also liked

ESC guidelines on Cardiovascular diseases during pregnancy
ESC guidelines on Cardiovascular diseases during pregnancyESC guidelines on Cardiovascular diseases during pregnancy
ESC guidelines on Cardiovascular diseases during pregnancy
AinshamsCardio
 
Final pregnancy hd
Final pregnancy hdFinal pregnancy hd
Final pregnancy hdalatawi2
 
Cardiac diseases complicating pregnancy
Cardiac diseases  complicating pregnancyCardiac diseases  complicating pregnancy
Cardiac diseases complicating pregnancy
Arya Anish
 
Heart disease in pregnancy 20-5-10
Heart disease in pregnancy 20-5-10Heart disease in pregnancy 20-5-10
Heart disease in pregnancy 20-5-10rudrika
 
Pregnancy and Heart Disease
Pregnancy and Heart DiseasePregnancy and Heart Disease
Pregnancy and Heart Disease
Nizam Uddin
 
Pregnancy and heart diseases
Pregnancy and heart diseasesPregnancy and heart diseases
Pregnancy and heart diseasesSafoin Kadi
 
Cardiovascular disease students [compatibility mode]
Cardiovascular disease  students [compatibility mode]Cardiovascular disease  students [compatibility mode]
Cardiovascular disease students [compatibility mode]Osama Warda
 
Pregnancy & cvd
Pregnancy & cvdPregnancy & cvd
Pregnancy & cvd
Anand Manjunath
 
Cardiac disease with pregnancy
Cardiac disease with pregnancyCardiac disease with pregnancy
Cardiac disease with pregnancyAhmed Mowafy
 
Heart Disease & Pregnancy
 				Heart Disease & Pregnancy 				Heart Disease & Pregnancy
Heart Disease & Pregnancygolden4host
 
Heart diseases in pregnancy
Heart diseases in pregnancyHeart diseases in pregnancy
Heart diseases in pregnancy
Deepak Chinagi
 
Heart disease in pregnancy - Dr Taila Amber
Heart disease in pregnancy - Dr Taila AmberHeart disease in pregnancy - Dr Taila Amber
Heart disease in pregnancy - Dr Taila Amber
Taila Amber
 

Viewers also liked (13)

ESC guidelines on Cardiovascular diseases during pregnancy
ESC guidelines on Cardiovascular diseases during pregnancyESC guidelines on Cardiovascular diseases during pregnancy
ESC guidelines on Cardiovascular diseases during pregnancy
 
Final pregnancy hd
Final pregnancy hdFinal pregnancy hd
Final pregnancy hd
 
Cardiac diseases complicating pregnancy
Cardiac diseases  complicating pregnancyCardiac diseases  complicating pregnancy
Cardiac diseases complicating pregnancy
 
Heart disease in pregnancy 20-5-10
Heart disease in pregnancy 20-5-10Heart disease in pregnancy 20-5-10
Heart disease in pregnancy 20-5-10
 
Pregnancy and Heart Disease
Pregnancy and Heart DiseasePregnancy and Heart Disease
Pregnancy and Heart Disease
 
Pregnancy and heart diseases
Pregnancy and heart diseasesPregnancy and heart diseases
Pregnancy and heart diseases
 
Cardiovascular disease students [compatibility mode]
Cardiovascular disease  students [compatibility mode]Cardiovascular disease  students [compatibility mode]
Cardiovascular disease students [compatibility mode]
 
Pregnancy & cvd
Pregnancy & cvdPregnancy & cvd
Pregnancy & cvd
 
Pregnancy and Heart Disease
Pregnancy and Heart DiseasePregnancy and Heart Disease
Pregnancy and Heart Disease
 
Cardiac disease with pregnancy
Cardiac disease with pregnancyCardiac disease with pregnancy
Cardiac disease with pregnancy
 
Heart Disease & Pregnancy
 				Heart Disease & Pregnancy 				Heart Disease & Pregnancy
Heart Disease & Pregnancy
 
Heart diseases in pregnancy
Heart diseases in pregnancyHeart diseases in pregnancy
Heart diseases in pregnancy
 
Heart disease in pregnancy - Dr Taila Amber
Heart disease in pregnancy - Dr Taila AmberHeart disease in pregnancy - Dr Taila Amber
Heart disease in pregnancy - Dr Taila Amber
 

Similar to Heart disease during pregnancy

25. CARDIAC DISEASE IN PREGNANCY obgy.ppt
25. CARDIAC DISEASE IN PREGNANCY obgy.ppt25. CARDIAC DISEASE IN PREGNANCY obgy.ppt
25. CARDIAC DISEASE IN PREGNANCY obgy.ppt
jacobntanga
 
Pregnancy and heart disease copied by prof. Samir Rafla
Pregnancy and heart disease copied by prof. Samir RaflaPregnancy and heart disease copied by prof. Samir Rafla
Pregnancy and heart disease copied by prof. Samir Rafla
Alexandria University, Egypt
 
Cardiac Diseases in Pregnancy pptx
Cardiac Diseases in Pregnancy pptxCardiac Diseases in Pregnancy pptx
Cardiac Diseases in Pregnancy pptx
Havillah medical center
 
congenital heart disease.pdf
congenital heart disease.pdfcongenital heart disease.pdf
congenital heart disease.pdf
STUDYCORNER7
 
Caeserean section complicated by mitral stenosis
Caeserean section complicated by mitral stenosisCaeserean section complicated by mitral stenosis
Caeserean section complicated by mitral stenosisDhritiman Chakrabarti
 
cardiacdiseaseinpregnancy-220427173031.pdf
cardiacdiseaseinpregnancy-220427173031.pdfcardiacdiseaseinpregnancy-220427173031.pdf
cardiacdiseaseinpregnancy-220427173031.pdf
TemGemechu
 
Seminar on Congenital Heart Disease
Seminar on Congenital Heart DiseaseSeminar on Congenital Heart Disease
Seminar on Congenital Heart Disease
Soumen Sengupta
 
12774872.ppt
12774872.ppt12774872.ppt
12774872.ppt
abhimittal8
 
Pregnancy Management Guidelines in Women with Cardiac Diseases.ppt
Pregnancy Management Guidelines in Women with Cardiac Diseases.pptPregnancy Management Guidelines in Women with Cardiac Diseases.ppt
Pregnancy Management Guidelines in Women with Cardiac Diseases.ppt
IreenPahang
 
Acyanotic Heart Defects
Acyanotic Heart DefectsAcyanotic Heart Defects
Acyanotic Heart DefectsTosca Torres
 
hypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptxhypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptx
Dr. Rahul Shah
 
hypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptxhypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptx
RahulShah614508
 
Medical Complication Of Pregnancy
Medical Complication Of PregnancyMedical Complication Of Pregnancy
Medical Complication Of PregnancyDeep Deep
 
CARDIAC DISEASE IN PREGNANCY.pptx
CARDIAC DISEASE IN PREGNANCY.pptxCARDIAC DISEASE IN PREGNANCY.pptx
CARDIAC DISEASE IN PREGNANCY.pptx
SrishtiGupta304
 
pregnancy and cardiovascular disease.pptx
pregnancy and cardiovascular disease.pptxpregnancy and cardiovascular disease.pptx
pregnancy and cardiovascular disease.pptx
ashokgodara7848
 
pediatrics congenital heart disease
pediatrics congenital heart diseasepediatrics congenital heart disease
pediatrics congenital heart disease
getandale zeleke
 
complex medical disorders in pregnancy
 complex medical disorders in pregnancy  complex medical disorders in pregnancy
complex medical disorders in pregnancy
partha sarathi roy
 
Dhana presentation
Dhana presentationDhana presentation
Dhana presentation
Dhanalakshmi R
 
congenitalcadiac diseases.pptx
congenitalcadiac diseases.pptxcongenitalcadiac diseases.pptx
congenitalcadiac diseases.pptx
SachinDwivedi57
 

Similar to Heart disease during pregnancy (20)

25. CARDIAC DISEASE IN PREGNANCY obgy.ppt
25. CARDIAC DISEASE IN PREGNANCY obgy.ppt25. CARDIAC DISEASE IN PREGNANCY obgy.ppt
25. CARDIAC DISEASE IN PREGNANCY obgy.ppt
 
Pregnancy and heart disease copied by prof. Samir Rafla
Pregnancy and heart disease copied by prof. Samir RaflaPregnancy and heart disease copied by prof. Samir Rafla
Pregnancy and heart disease copied by prof. Samir Rafla
 
Cardiac Diseases in Pregnancy pptx
Cardiac Diseases in Pregnancy pptxCardiac Diseases in Pregnancy pptx
Cardiac Diseases in Pregnancy pptx
 
congenital heart disease.pdf
congenital heart disease.pdfcongenital heart disease.pdf
congenital heart disease.pdf
 
Caeserean section complicated by mitral stenosis
Caeserean section complicated by mitral stenosisCaeserean section complicated by mitral stenosis
Caeserean section complicated by mitral stenosis
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
 
cardiacdiseaseinpregnancy-220427173031.pdf
cardiacdiseaseinpregnancy-220427173031.pdfcardiacdiseaseinpregnancy-220427173031.pdf
cardiacdiseaseinpregnancy-220427173031.pdf
 
Seminar on Congenital Heart Disease
Seminar on Congenital Heart DiseaseSeminar on Congenital Heart Disease
Seminar on Congenital Heart Disease
 
12774872.ppt
12774872.ppt12774872.ppt
12774872.ppt
 
Pregnancy Management Guidelines in Women with Cardiac Diseases.ppt
Pregnancy Management Guidelines in Women with Cardiac Diseases.pptPregnancy Management Guidelines in Women with Cardiac Diseases.ppt
Pregnancy Management Guidelines in Women with Cardiac Diseases.ppt
 
Acyanotic Heart Defects
Acyanotic Heart DefectsAcyanotic Heart Defects
Acyanotic Heart Defects
 
hypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptxhypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptx
 
hypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptxhypertensive-disorders-of-pregnancy.pptx
hypertensive-disorders-of-pregnancy.pptx
 
Medical Complication Of Pregnancy
Medical Complication Of PregnancyMedical Complication Of Pregnancy
Medical Complication Of Pregnancy
 
CARDIAC DISEASE IN PREGNANCY.pptx
CARDIAC DISEASE IN PREGNANCY.pptxCARDIAC DISEASE IN PREGNANCY.pptx
CARDIAC DISEASE IN PREGNANCY.pptx
 
pregnancy and cardiovascular disease.pptx
pregnancy and cardiovascular disease.pptxpregnancy and cardiovascular disease.pptx
pregnancy and cardiovascular disease.pptx
 
pediatrics congenital heart disease
pediatrics congenital heart diseasepediatrics congenital heart disease
pediatrics congenital heart disease
 
complex medical disorders in pregnancy
 complex medical disorders in pregnancy  complex medical disorders in pregnancy
complex medical disorders in pregnancy
 
Dhana presentation
Dhana presentationDhana presentation
Dhana presentation
 
congenitalcadiac diseases.pptx
congenitalcadiac diseases.pptxcongenitalcadiac diseases.pptx
congenitalcadiac diseases.pptx
 

Recently uploaded

Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
AzmatAli747758
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 

Recently uploaded (20)

Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 

Heart disease during pregnancy

  • 1. This PowerPoint Presentation done by dr.Osama Khalil Obstetrics and Gynecology Department Ain Shams University
  • 2. Heart disease in pregnancy is very rare but potentially serious and complicates approximately 1% of all pregnancies. This Prevalence varies from one community to another principally because the incidence of rheumatic heart disease and undiagnosed or uncorrected congenital heart disease is higher in developing countries. Etiology • Rheumatic valve “commonest in Egypt and developing countries” • Congenital Heart diseases “commonest in developed countries” • Others: e.g. Arrhythmia and ischemic heart diseases “rare”
  • 3. A. Text here C. Text here physiological changes in CVS during pregnancy Irrespective of the underlying condition; pregnancy imposes a significant burden on the heart due to normal physiological changes occur; both blood volume and cardiac output are changed. The changes are classified in: Vascular resistance and blood pressure
  • 4. The Heart a. Lateral displacement of the Apex: in late pregnancy (to the 4th intercostal space) occur due to elevation of the diaphragm and the heart by the fundus of growing uterus. b. Functional systolic murmurs: due to hyper dynamic circulation of the dilutional anemia.
  • 5. Cardiac Output a. Preload: is increased due to associated Rise in the blood volume " main cause". b. Afterload: is reduced due to the decline in systemic vascular resistance. c. Maternal heart rate: rises by 15-20 beats/min rises to a peak at 28 to 34 weeks which is 30-50% above baseline because:
  • 6. Vascular resistance and Blood pressure BP typically fall early in gestation to about 5-10 mmHg below the baseline in the 2nd trimester "mean of about 105/60 mmHg". In 3rd trimester BP gradually increases and may normalize to non-pregnant values by term. The fall in BP is reduced by a reduction in systemic vascular resistance due to: a. Uteroplacental circulation. b. Systemic Vasodilatation Supine Hypotension $ In the 2nd half of pregnancy; maternal hypotension occurs in supine position due to pressure of pregnant uterus on the IVC this leads to Decrease venous return and cardiac output.
  • 7. The Veins Varicose veins, ankle edema and piles due to pressure by uterus on pelvic veins, progesterone effect and increased blood volume.
  • 8. NYHA (New York Heart Association) Functional grading of heart disease Grade Symptoms Degree of compromise I No limitation of physical activity- asymptomatic with normal activity Uncompromised II : Mild limitation of physical activity -Symptoms with normal physical activity Slightly compromised III : Marked limitation of physical activity -Symptoms with less than normal activity, comfortable at rest Markedly compromised IV Severe limitation of physical activity- symptoms at rest Severely compromised Grade I and II = 80% of the patientscompensated heart Grade III and IV 20% of the patients decompensated heart
  • 9. Diagnosis of Cardiac diseases during pregnancy including: History Taking Examinations Investigations
  • 10. History Taking Clinical Features of Normal pregnancy Mimic Heart Disease SYMPTOMS : 1- Dyspnea. 2- Orthopnoea. 3- Paroxysmal Nocturnal Dyspnea. 4- Easy fatigue. 5- Dizziness. Clinical indications of the Heart Disease during pregnancy SYMPTOMS : 1- Progressive Dyspnea or Orthopnoea. 2- Chest pain. 3- Nocturnal Cough. 4- Hemoptysis. 5- Syncope.
  • 11. Examinations Clinical Features of Normal pregnancy Mimic Heart Disease SIGNS : 1- Increased Pulse Rate. 2- Water Hummer Pulse. 3- Systolic Murmur. 4- Left Axis Deviation. 5- Edema. 6- congested Neck veins. Clinical indications of the Heart Disease during pregnancy SIGNS : 1- Cyanosis. 2- Clubbing Of fingers. 3- Persistent Arrhythmia. 4- Persistent Neck Veins. 5- criteria or Pulmonary HTN. 6- Cardiomegaly . 7- Diastolic Murmur. 8- Systolic Murmur more than or Equal grade 3/6. 9- Persistent split 2nd sound.
  • 12. Investigations 1- Echocardiogram. cardiac status and structural anomalies 2- ECG. 3- Catheterization rarely done, if done guided by transesophageal U/S.
  • 13. Next Effect of pregnancy on heart disease (medical complications) Effect of heart disease on pregnancy (Obstetric complications) • Worsening of cardiac status: Decomposition ( heart failure): a) During pregnancy: Increase COP at 28 -32 WKS. b) During labor: due to stress of labor . c) After delivery: the most dangerous period due to sudden return the blood to general circulation. • Bacterial endocarditis, pulmonary edema, pulmonary embolism, rupture of aneurism specially during labor. •Polyhydromaninos as a part of systemic venous congestion. •PPH: atonic due to uterine ischemia. •Puerperal sepsis and secondary postpartum hemorrhage. •Defective lactation.
  • 14. The Fetus is at increased risk of growth restriction and preterm delivery in pregnancies complicated by cyanotic congenital heart disease. When total fetal lose rate may be as higher as 40%. Uncorrected coarctation of aorta is associated with fetal growth restriction in more than 10% of cases due to reduced placental perfusion. The incidence of congenital Heart disease in general population is8 per 1000 live born babies if a parent is affected the risk is increase to 5%. Therefore all pregnant women with congenital heart disease should be Referred for export fetal cardiology scanning •Abortion especially with cyanotic heart disease or due to teratogenic drugs •Congenital fetal malformation due to chronic hypoxia or teratogenic drugs •IUGR. •Congenital heart disease in baby 5%. •Neonate anemia and hypoxia.
  • 15. The three categories are lesions that produce volume overload, lesions that produce pressure overload, and lesions that produce cyanosis. Other cardiac conditions which have their own unique issues are Cardiomyopathy, coronary artery disease and Marfans syndrome. 1-Volume overload lesions •Atrial septal defects •Ventricular septal defects •Patent ductus arteriosus •Mitral and aortic regurgitation (insufficiency 2-Pressure overload lesions •Congenital aortic stenosis •Coarctation of the aorta •Pulmonary valve stenosis •Rheumatic mitral stenosis 3-Cyanotic congenital disease heart •Ebstein’s anomaly •Tetralogy of Fallot
  • 16. Atrial septal defects The most common congenital lesions in adults are atrial septal defects and they may be first diagnosed during pregnancy The expected 50% increase in blood volume during pregnancy causes further volume loading, although usually without a concomitant increase in pulmonary artery pressures. Most patients with an isolated ASD tolerate pregnancy well; good left ventricular ejection fraction and NYHA functional status are predictive of uncomplicated and successful outcomes With larger defects and shunts, there is risk for congestive heart failure, atrial arrhythmias, peripheral venous thrombosis or embolism, cerebral vascular accidents, and shunt reversal with cyanosis from sudden systemic hypotension. 1-Volume overload lesions
  • 17. 1-Volume overload lesions Ventricular septal defects Clinical sequelae and symptoms manifest as exercise intolerance, dyspnea or congestive heart failure are most likely to happen if the VSD is large in size and therefore exerts a hemodynamic effect. Infective endocarditis, however, can occur with any size of VSD. Similarly to ASD, VSD should be repaired if symptomatic, large (a Qp:QS ratio of >1.5:1) or associated with an elevation in pulmonary artery pressure. Isolated VSD are usually well tolerated in pregnancy unless the size is large and degree of shunting places a large volume burden on the system; peripartum risks are determined by parameters which reflect the degree of shunting: left ventricular size and function, pulmonary artery pressures, and the patient’s functional class. In hemodynamically significant shunts, complications include congestive heart failure, atrial arrhythmias, worsening pulmonary artery hypertension, and shunt reversal with cyanosis due to systemic hypotension. In a study from Connecticut, USA, in the 1970s, there were no maternal deaths reported in 98 pregnancies resulting in 78 liveborn infants in 50 women with VSD ,In women with corrected lesions, no increased risks are associated with gestation.
  • 18. Patent ductus arteriosus the risks of pregnancy are related to shunt size and degree of pulmonary hypertension. Clinical symptoms and complications are also similar to those associated with VSD. In corrected or uncorrected patent ductus arteriosus, pulmonary hypertension significantly increases maternal and fetal morbidity and mortality rates 1-Volume overload lesions
  • 19. 1-Volume overload lesions Mitral and aortic regurgitation (insufficiency) Valvular regurgitation may be due to rheumatic disease, prolapse or endocarditis. It can also occur in relation to ischemic heart disease and dilated cardiomyopathies. Trivial or physiologic regurgitation of the mitral valve is present in up to 70% of normal patients on echocardiography; it is not audible and is of no clinical significance. Complications occur from valvular regurgitation as a result of chronic volume overload and related atrial or ventricular strain and can include arrhythmias (especially atrial fibrillation in the setting of mitral regurgitation), pulmonary hypertension (particularly from chronic severe mitral insufficiency or congestive heart failure. If found in isolation, these lesions are usually well tolerated in pregnancy. Due to the favorable effects of decreased systemic vascular resistance and consequent afterload reduction in pregnancy, even severe regurgitation does not exhaust the cardiac reserve. On the other hand, those patients with chamber enlargement or ventricular dysfunction have higher rates of peripartum heart failure and this should be anticipated
  • 20. Rheumatic mitral stenosis Patients with mild stenosis are asymptomatic. Those with moderate stenosis are asymptomatic at rest. Symptoms can include limited exercise tolerance, dyspnea on exertion or, when supine, hemoptysis, and pedal edema. Unless the mitral stenosis is severe, most patients are asymptomatic. 2-Pressure overload lesions
  • 21. Coarctation of aorta Risk of rupture in late pregnancy or labor Coarctation of the aorta The risks of pregnancy in women with aortic coarctation include worsening hypertension, new-onset heart failure and, rarely but ominously, aortic dissection and rupture .Ideally, moderate-to- severe aortic coarctation should be repaired, with balloon angioplasty or stenting, or replacement prior to pregnancy 2-Pressure overload lesions
  • 22. aortic stenosis Left-sided congestive failure Congenital aortic stenosis Isolated mild-to-moderate valvular aortic stenosis is well tolerated in pregnancy, but severe aortic stenosis (aortic valve area (AVA) <1.0 cm2 – the normal aortic valve area is 3–4 cm2) is associated with increased maternal and fetal morbidity and mortality rates. 2-Pressure overload lesions
  • 23. Pulmonary valve stenosis Patients with unrepaired mild-to-moderate pulmonary stenosis (gradients less than 40 mmHg; normally there should be no gradient across any valve) are usually asymptomatic and tolerate the hemodynamic burden of pregnancy with a low incidence of complications In patients with more severe obstruction and worsening clinical function, Percutaneous balloon valvuloplasty can be done during pregnancy. 2-Pressure overload lesions
  • 24. Ebstein’s anomaly In this uncommon congenital heart lesion, a malformed tricuspid valve is apically displaced to a variable extent with resultant tricuspid regurgitation, atrial dilation, and limited right ventricular function. Severe cases present in infancy, but many cases will first present in teenagers or adults. Complications include CHF, arrhythmias, and paradoxical embolism. Associated abnormalities are frequent and include ASD (50%) and the Wolff–Parkinson–White (WPW) syndrome (30%) . Most patients can be treated medically but more severe forms may develop right heart failure and require surgical correction. Preconception repair is preferred to reduce morbidity and mortality Approximately 70% of women with Ebstein’s anomaly have an interatrial shunt, and therefore these women are also at risk for paradoxic emboli (venous thromboembolism that passes through an ASD into the left atrium and thereby the systemic-arterial circulation to cause stroke or peripheral embolism). 3-Cyanotic congenital disease heart
  • 25. 3-Cyanotic congenital disease heart Tetralogy of Fallot The most common cyanotic congenital heart defect found in children, adults, and pregnant women In a recent retrospective study of 50 pregnancies that did not end in abortions in 26 women, the maternal complication rate was 12% (of pregnancies) and 19% (of patients) cardiac complications included symptomatic right-sided heart failure in two cases and arrhythmias (three ventricular and three supraventricular) All patients were NYHA class I prior to pregnancy. The two patients with heart failure were noted to have severe pulmonary insufficiency which would further increase the volume load on the right ventricle . On the other hand, uncorrected or palliated lesions can be expected to have clinical deterioration during pregnancy, resulting in increased maternal and fetal complications In these patients, maternal risks include increased right- to-left shunting via a residual VSD due to the normal fall in systemic vascular resistance and, thus, worsening cyanosis during gestation and delivery; biventricular heart failure; arrhythmias; and cerebral vascular accidents from paradoxic emboli. Fetal risk is correlated with maternal hypoxia and includes a very high rate of prematurity, low birthweight, and spontaneous abortion .
  • 26. Maternal cardiac arrhythmias Maternal cardiac arrhythmias are occasionally encountered during pregnancy. Paroxysmal atrial tachycardia is the most commonly encountered maternal arrhythmia and is usually associated with overly strenuous exercise. Underlying cardiac disease such as mitral stenosis should be suspected when atrial fibrillation and flutter are encountered Other cardiac disease
  • 27. Peripartum Cardiomyopathy: Peripartum Cardiomyopathy is an unusual but especially severe cardiac condition identified in the last month of pregnancy or the first 6 months following delivery. It is difficult to distinguish from other cardiomyopathies (e.g., myocarditis) except for its association with pregnancy. In many cases, no apparent cause can be determined. Other cardiac disease
  • 28. Eisenmenger’s syndrome. if right-to-left shunt—pulmonary hypertension. Other cardiac disease •Artificial valves—thrombosis
  • 29. Coronary artery disease Atherosclerotic coronary artery disease is rare in premenopausal women, but with increases in smoking, obesity, diabetes and delayed childbearing, ischemic heart disease is now being seen in pregnancy more frequently. Pregnancy increases the risk of myocardial infarction 3–4-fold. Acute myocardial infarction was reported to occur with a frequency of 10/100,000 deliveries and a Medline search of case reports suggests a very high maternal mortality rate (19–35%) Other cardiac disease
  • 30. Cardiac transplantation The number of women deciding to become pregnant after cardiac transplantation has increased as more recipients are surviving longer and with an improved quality of life. Pregnancy does not appear to have an adverse effect with respect to cardiac function or episodes of rejection Other cardiac disease
  • 31. Marfan’s syndrome Pregnancy in women with the Marfan syndrome carries risk for worsening aortic dilation, aortic valve regurgitation, congestive heart failure, and, more ominously, acute aortic dissection and death Preconception aortic replacement or pregnancy termination should be strongly considered for patients with ascending aortic diameters greater than or equal to 4.5 cm On the other hand, women without aortic dilation or cardiovascular complications appear to tolerate pregnancy well Other cardiac disease
  • 32. Ehlers–Danlos type IV Type IV or vascular EDS is the most dangerous type of EDS and may result in death related to arterial, intestinal and uterine fragility or rupture. The heredity pattern is autosomal dominant. Overall life expectancy is estimated to be 40–50 years, and most deaths are secondary to arterial rupture. Maternal mortality rate is approximately 12%, with the greatest risk of complications occurring during labor, delivery and early postpartum periods. Although uterine rupture has been cited as the most common cause of maternal mortality related to EDS type IV. Other cardiac disease
  • 33. For all women with CHD, counseling about future pregnancies and contraception should begin in adolescence to prevent accidental and potentially dangerous pregnancies. To obtain correct and complete information for risk stratification, a thorough evaluation should be performed including • Review of past medical records, • Assessment of current functional status, • Physical examinations, • Pulse oximetry, • Electrocardiogram, • Imaging studies, • Cardiopulmonary • Exercise test and the use of Halter monitors.
  • 34. Risk stratifications of preconception management Risk assessment, by modified World Health Organization (WHO) risk classification, was recommended by the European Society of Cardiology (ESC) to estimate the risk of pregnancy in women with heart disease Four risk classes (WHO I, II, III and IV) were defined according to both specific heart lesions and the clinical cardiac status The categories ranged from the very low risk of WHO class I to the highest risk of WHO class IV, which was considered the contraindication for pregnancy. The table in the Next slide
  • 35. WHO I No significant risk elevation WHO II depending on individual Mildly to moderately elevated risk WHO III Significantly elevated risk WHO IV High risk (pregnancy contraindicated) •Uncomplicated, small or mild -pulmonary stenosis -patent ductus arteriosus -Mitral valve prolapse • Successfully repaired simple lesions -atrial or ventricular septal defect, -patent ductus arteriosus-anomalous p ulmonary venous drainage. •Atrial or ventricular ectopic beats, isolated WHO II Mildly elevated Risk. •Unoperated atrial or ventricular septal defect (no elevated pulmonary artery pressure) • Repaired tetralogy of Fallot (without relevant residua or sequelae) • Most arrhythmias • Mild left ventricular Impairment. •Hypertrophic Cardiomyopathy. •Native or tissue valvular heart disease not Considered WHOI or IV •Marfan syndrome without aortic dilatation. •Aorta < 45 mm in aortic disease associated with bicuspid aortic valve. •Repaired coarctation •Non-severe systemic ventricular dysfunction. •Mechanical valve. •Systemic right ventricle. •Cyanotic heart disease (unrepaired without pulmonary hypertension). •Other complex congenital heart Disease. •Aortic dilatation 40-45 mm in Marfan syndrome. • Aortic dilatation 45-50 mm in aortic disease associated with bicuspid aortic valve. •Pulmonary arterial hypertension of any cause • Severe systemic ventricular dysfunction (LVEF < 30%, NYHA III-IV). • Previous peripartum Cardiomyopathy with any residual impairment of left ventricular function. •Severe mitral stenosis, severe symptomatic aortic stenosis, severe coarctation. •Marfan syndrome with aorta dilated > 45 mm. • Aortic dilatation > 50 mm in aortic disease associated with bicuspid aortic valve • Native severe coarctation
  • 36. The flowchart for preconception assessment and counseling for women with congenital heart disease. CPX, cardiopulmonary exercise test; PE and WHO
  • 37. Antenatal Management •Place In most of cases, patients are followed up in special cardiac out patient clinic under Under supervision of both obstetricians, cardiologists and anesthesiologist . Antenatal care visits more frequent for adequate follow up of maternal cardiac state And fetal well-being. Indication of hospitalization includes: 1) Cases of class II at 24-32 weeks of pregnancy. 2) Cases of class III and IV are admitted earlier and for longer periods. 3) Near term to plan for delivery.
  • 38. Antenatal Management •Drug therapy a) Prophylaxis against rheumatic activity  antibiotics Indication: patients with rheumatic heart lesion Drug used: 1) Long acting penicillin or daily penicillin 2) Erythromycin (if sensitive to penicillin) b) Prophylaxis against of infective endocarditis  antibiotics Indications: - Patients need prophylaxis : patient with problems affecting the structure of the Heart (e.g. replacement heart valve congenital heart disease hypertrophic Cardiomyopathy. patient with pervious history of Invective Endocarditis. - Conditions need prophylaxis: Before any minor surgery (e.g. tooth extraction) and labor or CS Drug used: a) At onset of labor or ROM to prior to CS or minor surgery by ½ hour.  Amoxicillin 1or 2 gm IV plus b) Then: amoxicillin 500 mg oral after 6 hours c) For women who are allergic to penicillin: vancomycin 1 gm IV. Next
  • 39. Antenatal Management •Drug therapy c) Prophylaxis against thrombosis antithrombotic drugs Indication: for patients with metallic valves. Drug used: choice of 3 regimens: 1) LMWH through out pregnancy, weight-adjusted dose with anti-Xa level monitoring 2) Warfarin through out pregnancy, if can keep warfarin less than or equal 5 mg e.g. INR 2-3 in aortic prosthesis, sinus rhythm, change to LMWH or UFH at 36 weeks. 3) LMWH until 13 weeks, and then warfarin and aspirin until 36 weeks; change to LMWH or UFH until labor. Monitoring anti-Xa level with LMWH. d) Treatment of heart failure and Acute pulmonary edema:  Fowler position  Opioid (morphine)  Oxygen  Drugs: Digitalis Diuretics  Frusemide 20-25 mg. Dilators  Hydralazine in hypertension
  • 40. Antenatal Management •Surgery in Pregnancy A) Balloon catheterization or even closed heart operation: could be done in 2nd trimester in case of severe mitral stenosis. B) Valve Replacement: indicated only in life threaten cases during pregnancy; as it need open heart surgery with heart-lung machine
  • 41. Antenatal Management •Follow Up a) Maternal condition:  Routine antenatal tests.  Cardiac assessment and early detection of heart failure  Recognition of risk factors “anemia, infection Or hypertension”.  Investigations “Echocardiogram, ECG, CBC and sputum culture for chest infection b) Fetal condition: Follow up of fetal kicks with regular tests of fetal wellbeing. •Other instructions and interventions  No heavy work and bed rest; 9 hours by night, 2 hours by day.  Guard against excessive weight gain.  Salt restrictions.  Correction of anemia.  Dental care and use of an umbrella of antibiotics when there is tooth extraction  Control of any Risk Factors eg. Anemia, infection Or hypertension.  Antenatal corticosteroids if preterm labor occurs or is indicated.
  • 42. Termination of pregnancy •Indications: a) Gestational age:  Pregnant women with cardiac disease who are considered functionally normal be allowed to go in to labor spontaneously  If there are any concerns about the functional adequacy of the heart and circulation, labor should be induced under controlled conditions the timing of induction is individualized taking into account the patient cardiac status inducibility of the cervix fetal lung maturity. b) Maternal condition: development of obstetric or medical complication inducing delivery. c) Fetal condition: Non-reassuring fetal rate evaluation, non-reassuring biophysical scores, IUFD or malformation Incompatible with life d) Other indication for termination: e.g the patient is in labor
  • 43. Termination of pregnancy •Mode of termination: a) Vaginal delivery:  Virtually all women with cardiac disease can expect to attempt vaginal delivery because it poses less cardiac risk than cesarean delivery. A long induction in a woman with an unfavorable cervix should be avoided b) Cesarean delivery:  Should be reserved for obstetric indications such as : - Fetal heart tracing is non-reassuring and vaginal delivery is not imminent. - Vaginal delivery is contraindicated eg. Placenta previa, prior classical cesarean delivery - Vaginal delivery is unsuccessful “ Failure to progress”  Cesarean delivery in cardiac diseased women is indicated in - Pre-term labor in patient on oral anti-coagulants. - Marfan and other ascending aortic aneurysms. - Aortic dissection. - Severe Aortic stenosis. - Eisenmenger’s syndrome. The concerns about cesarean delivery - General anesthesia, if required, incurs the risk of hemodynamic instability. -CS is accompanied by blood loss that is about twice as great as with vaginal delivery. -There are increased risks of wound and uterine infection. -Postoperative thrombophlebitis is more common after CS. -The risk of postoperative incisional bleeding is high in patients requiring anticoagulants.
  • 44. Termination of pregnancy •Intra-partum Management :  Delivery in semi-sitting (Fowler) position with adequate oxygenation.  Staining is prohibited, to minimize venous return and decrease heart rate.  Proper pain relief to minimize anxiety and tachycardia.  Close observation to avoid PPH.  Avoid early ROM and Excessive PV to avoid infection.  Fluid restriction and anti-failure measures in cases at high risk for heart failure.  Antibiotic prophylaxis against Infective Endocarditis.  Shorten the second stage by low-forceps when necessary. Epidural anesthesia may sometimes cause systemic hypotension, so it contraindicated in cases with right-left shunt. Also it is not suitable for patients on anticoagulants
  • 45. Termination of pregnancy •Post-Partum Management :  Measures to avoid PPH: - Oxytocin should be infused slowly (less than 2 units/min) to avoid hypertensive effect. - Ergometrin should be avoided in most patients (high rate of vasoconstriction and elevation of blood pressure  Hemodynamic monitoring of the mother is warranted for 12-24 hours after delivery.  In patients requiring prolonged bed rest: - Meticulous leg care. - Elastic support stockings. - Early ambulation are important preventive measures that reduce the risk of VTE.  Warfarin is started 2-3 days post-partum if patient is on anticoagulant therapy.  Prophylaxis and treatment of expected anemia.  Prophylactic antibiotics against sepsis.  Anti-D Ig should be given to all non-sensitized RhD-negative women.  Care of the neonate.  Breast-feeding is contraindicated only if there is heart failure.  Proper selection of a method of contraception, for adequate pregnancy spacing.
  • 46. In pregnant women with cardiac disease Which cardiac patients should be referred to hospital for an abortion? • Congenital – Cyanotic disease, right/left ventricular dilatation, uncontrolled tachyarrhythmia • Coronary disease  History of AMI, treatment angina. • Cardiomyopathy Dilated, hypertrophic, history of peripartum CMP. • Valvular disease  Significant aortic/mitral stenosis  Aortic/mitral regurgitation with LV dilatation. Abortion in women with significant cardiac disease • Identify the women with cardiovascular disease by -European Society of Cardiology guidelines or WHO Classifications • Consult a cardiologist – Not all cardiac diseases are alike • Consult an anesthesiologist experienced in cardiac anesthesia – Follow selected patients (pulmonary hypertension!) long enough(at least overnight)
  • 47. Medical vs. surgical abortion in women with significant cardiac disease The medical abortion method is also referred to as the “abortion pill” method. Medical abortion is an abortion caused by medicine rather than surgery. Two medications are used in medical abortions: Mifepristone and misoprostol. It is only available in women who are less than 7 weeks pregnant Cervical Ripening MIFEPRISTONE Causes progesterone blockade Decidual Necrosis Detachment MISOPROSTOL Causes uterine cramping & expulsion
  • 48. A surgical abortion also known as aspiration abortion, empties the contents of your uterus and is usually performed within 12-14 weeks from your last normal menstrual period. Two types of surgical abortion: Vacuum Aspiration Manual Vacuum Aspiration (MVA) removes the fetus/embryo by suction using a manual syringe. Electric Vacuum Aspiration (EVA) which uses an electric pump to remove the fetus/embryo. Dilation and Evacuation is done in the second 12 weeks (2nd trimester) of pregnancy. It usually includes a combination of vacuum aspiration, dilation and curettage (D&C), and the use of surgical instruments (such as forceps). Medical vs. surgical abortion in women with significant cardiac disease
  • 49.
  • 50. • Obstetrics book volume I of obstetrics and Gynecology department of faculty of medicine of Ain Shams university • Obstetric_by_10_Teachers_18th_Edition /Campball lees • Of obstetrics and Gynecology book sixth edition by Charles R.B. Beckmann, Frank W.Ling, Barbara M. Barzansky, ….etc. • Lecture Note Obstetrics and Gynecology by Diana Hamilton-Fairley MD, FRCOG Consultant Obstetrician and Gynecologist Guy’s and St Thomas’s Hospital NHS Trust, London Second Edition • de Swiet's Medical Disorders in Obstetric Practice Edited by Raymond O. Powrie, MD Michael F. Greene, MDWilliam Camann, MD WILEY-BLACKWELL • Nelson-Piercy C. Heart disease. In: Handbook of Obstetric Medicine -- Nelson-Piercy C, ed. (2002) 2nd Edn. Martin Dunitz: Taylor & Francis Group. •Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31:2124–2132. [PubMed] • Kaleschke G, Baumgartner H. Pregnancy in congenital and valvular heart disease. Heart. 2011;97:1803–1809. [PubMed] • European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society forGender Medicine (DGesGM) Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Committee for Practice Guidelines. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on theManagement of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) Eur Heart J. 2011;32:3147– 3197. [PubMed] • Abortion in women with cardiac disease/ Oskari Heikinheimo Dept Ob&Gyn University of Helsinki Soc Fam Plan, Contraception 2012